A case of primary malignant melanoma of the pleura

Misa Nakano, Tomomi Ujino, Masakazu Takahara, Uchi Hiroshi, Yoichi Moroi, Masutaka Furue

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A 57-year-old woman presented with appetite loss, malaise and dyspnea in August 2007. Chest radiograph showed left pleural effusion and thickening of the left pleura, and thoracic drainage was performed. Positron emission tomography (PET) showed multiple sites of uptake within the left pleura indicating malignant tumors. No uptake was seen in other parts of her body. An open lung biopsy disclosed multiple black-colored masses widely disseminated in the left thoracic cavity, and partial resection was performed. Pathological diagnosis was malignant melanoma. She was admitted to our hospital in September 2007. Repeated physical examinations failed to reveal any site for the primary melanoma in the skin, eyes, oral cavity, or genital or anal regions, and neither computed tomography (CT) nor PET showed masses in other parts of her body. Thus, a diagnosis of primary malignant melanoma of the pleura was made. Beginning in October 2007, she received 2 courses of DAC-Tam (DTIC, ACNU, CDDP and Tamoxifen) therapy, a single course of CDV (CDDP, DTIC, VDS) therapy, and then 6 courses of triweekly paclitaxel therapy. But metastasis to the liver and abdominal lymph nodes appeared. Chemotherapy was discontinued and beginning in August 2008, she was treated with subcutaneous injection of IFN-β every other week. However, she died from multiple metastases in May 2009, a year and 9 months after the diagnosis.

Original languageEnglish
Pages (from-to)595-599
Number of pages5
JournalNishinihon Journal of Dermatology
Volume72
Issue number6
DOIs
Publication statusPublished - Dec 1 2010

Fingerprint

Pleura
Melanoma
Dacarbazine
Human Body
Thorax
Nimustine
Neoplasm Metastasis
Thoracic Cavity
Appetite
Pleural Effusion
Tamoxifen
Subcutaneous Injections
Paclitaxel
Positron-Emission Tomography
Dyspnea
Physical Examination
Mouth
Drainage
Therapeutics
Lymph Nodes

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

A case of primary malignant melanoma of the pleura. / Nakano, Misa; Ujino, Tomomi; Takahara, Masakazu; Hiroshi, Uchi; Moroi, Yoichi; Furue, Masutaka.

In: Nishinihon Journal of Dermatology, Vol. 72, No. 6, 01.12.2010, p. 595-599.

Research output: Contribution to journalArticle

Nakano, M, Ujino, T, Takahara, M, Hiroshi, U, Moroi, Y & Furue, M 2010, 'A case of primary malignant melanoma of the pleura', Nishinihon Journal of Dermatology, vol. 72, no. 6, pp. 595-599. https://doi.org/10.2336/nishinihonhifu.72.595
Nakano, Misa ; Ujino, Tomomi ; Takahara, Masakazu ; Hiroshi, Uchi ; Moroi, Yoichi ; Furue, Masutaka. / A case of primary malignant melanoma of the pleura. In: Nishinihon Journal of Dermatology. 2010 ; Vol. 72, No. 6. pp. 595-599.
@article{b9f66f890c834b1eb609b4c3804f535e,
title = "A case of primary malignant melanoma of the pleura",
abstract = "A 57-year-old woman presented with appetite loss, malaise and dyspnea in August 2007. Chest radiograph showed left pleural effusion and thickening of the left pleura, and thoracic drainage was performed. Positron emission tomography (PET) showed multiple sites of uptake within the left pleura indicating malignant tumors. No uptake was seen in other parts of her body. An open lung biopsy disclosed multiple black-colored masses widely disseminated in the left thoracic cavity, and partial resection was performed. Pathological diagnosis was malignant melanoma. She was admitted to our hospital in September 2007. Repeated physical examinations failed to reveal any site for the primary melanoma in the skin, eyes, oral cavity, or genital or anal regions, and neither computed tomography (CT) nor PET showed masses in other parts of her body. Thus, a diagnosis of primary malignant melanoma of the pleura was made. Beginning in October 2007, she received 2 courses of DAC-Tam (DTIC, ACNU, CDDP and Tamoxifen) therapy, a single course of CDV (CDDP, DTIC, VDS) therapy, and then 6 courses of triweekly paclitaxel therapy. But metastasis to the liver and abdominal lymph nodes appeared. Chemotherapy was discontinued and beginning in August 2008, she was treated with subcutaneous injection of IFN-β every other week. However, she died from multiple metastases in May 2009, a year and 9 months after the diagnosis.",
author = "Misa Nakano and Tomomi Ujino and Masakazu Takahara and Uchi Hiroshi and Yoichi Moroi and Masutaka Furue",
year = "2010",
month = "12",
day = "1",
doi = "10.2336/nishinihonhifu.72.595",
language = "English",
volume = "72",
pages = "595--599",
journal = "Nishinihon Journal of Dermatology",
issn = "0386-9784",
publisher = "Kyushu University, Faculty of Science",
number = "6",

}

TY - JOUR

T1 - A case of primary malignant melanoma of the pleura

AU - Nakano, Misa

AU - Ujino, Tomomi

AU - Takahara, Masakazu

AU - Hiroshi, Uchi

AU - Moroi, Yoichi

AU - Furue, Masutaka

PY - 2010/12/1

Y1 - 2010/12/1

N2 - A 57-year-old woman presented with appetite loss, malaise and dyspnea in August 2007. Chest radiograph showed left pleural effusion and thickening of the left pleura, and thoracic drainage was performed. Positron emission tomography (PET) showed multiple sites of uptake within the left pleura indicating malignant tumors. No uptake was seen in other parts of her body. An open lung biopsy disclosed multiple black-colored masses widely disseminated in the left thoracic cavity, and partial resection was performed. Pathological diagnosis was malignant melanoma. She was admitted to our hospital in September 2007. Repeated physical examinations failed to reveal any site for the primary melanoma in the skin, eyes, oral cavity, or genital or anal regions, and neither computed tomography (CT) nor PET showed masses in other parts of her body. Thus, a diagnosis of primary malignant melanoma of the pleura was made. Beginning in October 2007, she received 2 courses of DAC-Tam (DTIC, ACNU, CDDP and Tamoxifen) therapy, a single course of CDV (CDDP, DTIC, VDS) therapy, and then 6 courses of triweekly paclitaxel therapy. But metastasis to the liver and abdominal lymph nodes appeared. Chemotherapy was discontinued and beginning in August 2008, she was treated with subcutaneous injection of IFN-β every other week. However, she died from multiple metastases in May 2009, a year and 9 months after the diagnosis.

AB - A 57-year-old woman presented with appetite loss, malaise and dyspnea in August 2007. Chest radiograph showed left pleural effusion and thickening of the left pleura, and thoracic drainage was performed. Positron emission tomography (PET) showed multiple sites of uptake within the left pleura indicating malignant tumors. No uptake was seen in other parts of her body. An open lung biopsy disclosed multiple black-colored masses widely disseminated in the left thoracic cavity, and partial resection was performed. Pathological diagnosis was malignant melanoma. She was admitted to our hospital in September 2007. Repeated physical examinations failed to reveal any site for the primary melanoma in the skin, eyes, oral cavity, or genital or anal regions, and neither computed tomography (CT) nor PET showed masses in other parts of her body. Thus, a diagnosis of primary malignant melanoma of the pleura was made. Beginning in October 2007, she received 2 courses of DAC-Tam (DTIC, ACNU, CDDP and Tamoxifen) therapy, a single course of CDV (CDDP, DTIC, VDS) therapy, and then 6 courses of triweekly paclitaxel therapy. But metastasis to the liver and abdominal lymph nodes appeared. Chemotherapy was discontinued and beginning in August 2008, she was treated with subcutaneous injection of IFN-β every other week. However, she died from multiple metastases in May 2009, a year and 9 months after the diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=79551599735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551599735&partnerID=8YFLogxK

U2 - 10.2336/nishinihonhifu.72.595

DO - 10.2336/nishinihonhifu.72.595

M3 - Article

AN - SCOPUS:79551599735

VL - 72

SP - 595

EP - 599

JO - Nishinihon Journal of Dermatology

JF - Nishinihon Journal of Dermatology

SN - 0386-9784

IS - 6

ER -